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Abstract    33 
Objective: The phase angle identifies changes in tissue’s electrical properties assessed by 34 
bioelectrical impedance measurement and it can predict prognosis in some conditions. 35 
Percutaneous endoscopic gastrostomy (PEG) is commonly used in patients with severe 36 
nutritional problems, but there is a need to improve the clinical decision-making for using 37 
PEG. We examined if a decreased phase angle predicts complications, short-term mortality 38 
(within 60 days of PEG insertion), or inflammatory markers (high C-reactive protein [CRP] 39 
levels or low albumin levels) following PEG insertion.  40 
Material and Methods: The phase angle was assessed from body resistance and reactance 41 
as measured by bioelectrical impedance in 131 patients admitted for PEG. Anthropometrics 42 
and clinical biochemical measures were collected at the time of PEG insertion, while 43 
complications and mortality were assessed at clinical follow-ups. Multivariable logistic 44 
regression analysis provided odds ratios (ORs) with 95% confidence intervals (CIs) adjusted 45 
for sex, age, body mass index and comorbidity. 46 
Results: A decreased phase angle did not statistically significantly increase the probability 47 
of acute complications or short-term mortality, but predicted increased inflammatory markers 48 
(CRP ≥10 mg/L (OR 1.63, 95% CI 1.02-2.60), albumin <30g/L (OR 2.10, 95% CI 1.24-3.57) 49 
and a combination of CRP ≥10 mg/L and albumin <30g/L (OR 3.06, 95% CI 1.51-6.19)).  50 
Conclusions: A decreased phase angle did not predict acute complications or short-term 51 
mortality after PEG insertion, but predicted increased levels of inflammatory markers. 52 
Keywords: complications; early mortality; enteral nutrition; malnutrition. 53 
54 
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Introduction  55 
Percutaneous endoscopic gastrostomy (PEG) is a procedure undertaken for those in need of 56 
nutritional supplementation over a longer or lifelong perspective, e.g. patients with cancer or 57 
neurological diseases (1, 2). The insertion of a PEG is usually technically easy, yet the 58 
procedure entails a complication rate of about 50% (3). A wide range of complications may 59 
occur, including leakage from the stoma in the abdominal wall and deeper situated infections 60 
with high risk of mortality. A combination of high C-reactive protein (CRP) and low albumin 61 
levels at the time of PEG insertion are markers of more vulnerable patients at a substantial 62 
risk of mortality (4). Old age, low body mass index (BMI) and comorbidity are other risk 63 
factors for severe complications after PEG insertion (5-7). Moreover in some situations 64 
decisions about inserting a PEG must include serious ethical considerations, e.g., in patients 65 
with dementia or in patients who are expected to die within a limited time frame (8, 9) 66 
The phase angle is measured by bioelectrical impedance, which estimates the body 67 
composition (10) by measurement of body resistance and reactance to electrical current. 68 
While resistance depends on the bodily fluid and electrolyte content, the reactance is 69 
produced by cell membranes when storing parts of charge as a capacitor. The phase angle 70 
measures the cell membrane function obtained from the relation between resistance and 71 
reactance at 50 kHz. The phase angle is a direct and objective parameter without need for data 72 
on weight and height (11), which can predict prognosis in a variety of diseases.  73 
The aim of the present study was to determine if phase angle predicts acute complications, 74 
short-term mortality and increased levels of inflammatory markers (high CRP levels and/or 75 
low albumin levels) after insertion of PEG, which could guide the clinical decision-making.  76 
 
77 
78 
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Methods 
79 
Study design  
80 
This was a prospective cohort study carried out at the Karolinska University Hospital in 
81 
Stockholm, Sweden. The exposure was phase angle and the outcomes were acute 
82 
complications, short-term mortality, high CRP levels and low albumin levels. The data 
83 
collection has been described in detail elsewhere (12). In brief, consecutive patients requiring 
84 
PEG were prospectively included in the study before PEG insertion. Patients were excluded if 
85 
they declined, if for any reason it was not possible to perform the bioelectrical impedance 
86 
spectroscopy measurement, or if the patients had a contraindication for bioelectrical 
87 
impedance measurement (metal prostheses or cardiac failure). For each patient, clinical and 
88 
treatment-related data were collected prior to PEG insertion according to a predefined study 
89 
protocol to ensure completeness and uniformity, and blood samples were drawn before the 
90 
PEG insertion for analyses of CRP and albumin. Weight was measured using a sitting 
91 
weighing scale and height by half demi span (measured from the fingertip to the sternal notch 
92 
using the left arm whenever possible) (13); BMI (kg/m2) was then calculated. All patients 
93 
routinely fasted for 6 hours before the PEG procedure. The patients were followed up at a 
94 
specialised clinic after PEG insertion.   
95 
 
96 
Exposure – phase angle 
97 
The study exposure was the phase angle value just before the insertion of the PEG. 
98 
Bioelectrical impedance spectroscopy (BodyScout, Fresenius Kabi) was used to assess the 
99 
phase angle at 50 kHz. Just before the PEG insertion, the bioelectrical impedance 
100 
measurement was carried out by a trained nurse or dietitian. The participants were resting in 
101 
the supine position for at least 5 minutes before the tetrapolar whole body measurement, with 
102 
electrodes on the dorsal surface of the hand/wrist and the foot/ankle of the same side 
103 
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according to the manufacturer’s instructions. Four electrodes for single use were used. Phase 
104 
angle was calculated directly from the reactance and resistance. Phase angle is between 5
◦
 and 
105 
7
◦
 in healthy subjects (14). The higher the reactance, the higher the phase angle for any given 
106 
resistance.  
107 
 
108 
Outcomes 
109 
The primary outcomes were acute complications (yes/no) within 14 days of PEG insertion 
110 
and mortality (yes/no) occurring within 60 days of PEG insertion. Acute complications were 
111 
defined as peristomal infections, leakage, obstipation and abdominal pain and assessed at 
112 
follow-up visits at 7 and 14 days post-PEG. Mortality within 60 days was assessed by 
113 
linkages of personal identity numbers through the Swedish Registry of the Total Population. 
114 
Secondary outcomes were increased CRP (≥ 10 mg/L), decreased albumin (<30 g/L) or a 
115 
combination of the two.  
116 
 
117 
Statistical analysis 
118 
Multivariable logistic regression analyses were used to estimate odds ratios (ORs) with 95% 119 
confidence intervals (CIs). Phase angle was expressed as a linear dependent variable in this 120 
model. Adjustments were made for sex (male or female), age (<65 or ≥65 years), BMI (<20 121 
or ≥20) and comorbidity (cancer or other comorbidity [cardiovascular disease, neurological 122 
disease, or diabetes]). All statistical analyses were performed using the statistical software 123 
SAS (Statistical Package 9.3; SAS Institute Inc, Cary, NC). 124 
 
125 
Ethics 126 
Patients, often together with a caregiver or attending relatives, gave informed consent to 127 
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participate in the study. The study was approved by the Regional Ethical Review Board in 128 
Stockholm, Sweden. 129 
130 
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Results 
131 
Patients 132 
Among 270 patients receiving a PEG during the study period, 131 (49%) were included in the 133 
present study. Non-participation (n=139) was due to technical problems, patients declining 134 
participation, or the presence of metal prostheses or cardiac failure. Characteristics of the 135 
participants are presented in Table 1. Most patients were male and younger than 65 years and 136 
had cancer as the indication for PEG. One third of patients were underweight (BMI <20) at 137 
the time of PEG insertion. The median phase angle was 4.8, and was slightly lower in women 138 
(4.3) than men (4.8) (Table 1).  139 
 140 
Decreased phase angle in relation to outcomes  141 
The results from the multivariable model are presented in Table 2. There were no statistically 142 
significant associations between decreased phase angle and risk of complications (OR 0.91, 143 
95% CI 0.59-1.38) or mortality (OR 0.93, 95% CI 0.37-2.37). Decreased phase angle was 144 
moderately to strongly associated with increased CRP and decreased albumin levels. A one 145 
unit decrease in phase angle was associated with an increased risk of elevated CRP levels (OR 146 
1.63, 95% CI 1.02 -2.60) and low albumin levels (OR 2.10, 95% CI 1.24-3.57), as well as a 147 
substantially increased risk of having a combination of increased CRP and decreased albumin 148 
(OR 3.06, 95% CI 1.51-6.19).  149 
 150 
 151 
152 
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Discussion  153 
This study indicates that a decreased phase angle at the time for PEG insertion is associated 154 
with markers of inflammation - an increase in CRP, decreased albumin as well as both of 155 
these outcomes combined, but it did not predict the occurrence of acute complications or 156 
mortality within 60 days of PEG insertion.  157 
 158 
Strengths of the study include the prospective design, the valid data on the exposure and all 159 
outcomes, including objectively measured levels of CRP and albumin. Moreover, changes in 160 
phase angle might depend on sex, age, BMI and comorbidity and it was therefore an 161 
advantage that these variabl s were adjusted for in the multivariable model. Weaknesses 162 
include potential non-random non-participation, which introduces a risk of selection bias from 163 
including more healthy patients. Even though the cohort of 131 subjects is large when 164 
comparing with similar studies regarding bioelectrical impedance measurements, the 165 
statistical power to assess the outcomes complications and mortality was limited. Thus, the 166 
negative findings should be interpreted with caution. Another limitation is that different cut-167 
off values have been used in the literature to assess for phase angle in relation to diagnosis-168 
specific study populations (15). These might not be applicable for populations in a more 169 
general clinical situation (16) like for the heterogenic PEG population. To avoid this problem 170 
we instead used phase angle as a linear variable. Moreover, it should be acknowledged that 171 
complications might not only be due to the PEG insertion per se, but also be caused by 172 
metabolic disturbances related to refeeding of malnourished patients (17). 173 
 174 
Our results showed that a decreased phase angle was associated with a high CRP, a 175 
universally accepted indicator of systemic inflammation. Phase angle may be directly affected 176 
by a change in electric tissue properties due to the disease itself, inflammation or malnutrition, 177 
among others. The strong association between a decrease in phase angle and low albumin 178 
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levels in the present study might also be due to inflammation, rather than an indicator for 179 
malnutrition (18, 19), as it has historically been described (20). These associations are of 180 
clinical relevance since CRP and albumin levels have been shown to predict mortality 181 
following PEG insertion (5). This finding together with the simplicity and objectivity in the 182 
assessment of the phase angle indicate a potential role in the clinical decision-making in 183 
patients considered for PEG.     184 
 185 
In conclusion, a decreased phase angle reflects increased levels of inflammatory markers - 186 
CRP, albumin and a combination of the two. These biomarkers indicate worse outcomes 187 
following PEG. However, if the measurement of the phase angle actually facilitates clinical 188 
decision-making for PEG remains uncertain. 189 
 
190 
 
191 
192 
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260 
Table 1. Characteristics of 131 study patients receiving a  261 
percutaneous endoscopic gastrostomy (PEG) 262 
 Number Per cent 
Sex 
Female 46 35 
Male 85 65 
Age   
<65 75 5 
>=65 56 43 
 
Body mass index 
<20 41 31 
>=20 90 69 
Diagnosis   
Cancer 109 83 
No cancer 22 17 
Other diagnosis 30 23 
No other diagnosis 101 77 
 
Complications within 14 days 
 of PEG 
No  89 68 
Yes 42 32 
 
Mortality within 60 days  
of PEG 
 
No 124 95 
Yes 7 5 
CRP level (mg/L)   
<10 78 60 
>=10 47 36 
missing 6 5 
 
Albumin level (g/L) 
>30 92 70 
<30 32 24 
missing 7 5 
 
C-reactive protein level >=10  
and albumin>=30 
No 99 76 
Yes 25 19 
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missing 7 5 
 
Phase angle median 
Grouped 4.8  
Female 4.3  
Male 4.8  
263 
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Table 2. Phase angle in relation to outcome variables in study patients 264 
receiving a percutaneous endoscopic gastrostomy (PEG) 265 
 Patients  
Number 
Odds ratio* 95% confidence 
interval 
Acute complications     
No  89 1 Reference 
Yes 42 0.91 0.59 – 1.38 
Mortality within 60 days of PEG    
No  124 1 Reference 
Yes 7 0.93 0.37 – 2.37 
CRP    
< 10  78 1 Reference 
≥10 47 1.63 1.02 – 2.60 
Albumin    
≥30  92 1 Reference 
< 30 32 2.10 1.24 – 3.57 
CRP and albumin    
CRP<10 and albumin ≥ 30  70 1 Reference 
CRP≥10 and albumin < 30 25 3.06 1.51 – 6.19 
 266 
* Adjusted for sex, age, body mass index and comorbidity. 267 
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